Small Cap Foreign Biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Small Cap Foreign Biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: michael_f_murphy who wrote (36)	2/25/2000 12:34:00 PM
From: RWReeves	Read Replies (2) of 363

Right! Now lissen up mates. Take a good long lookity look at NVGN and see if it don't make yer Walla Be. Whatever. Anyway, looks interesting. NV-06 in phase I. Tox is probably going to be OK as its sort of a nutriceuticals based approach. But also this is a "picks and shovels" supplier to AU/NZ biotech. Up about 30% so still lots of room to grow. BTW Australia is one of the leading onc research regions of the world. Half of Amgen originally came from there, calls themselves the "Melbourne Mafia". Worth keeping them in mind. Good chaps very bright. As I am spamming other threads with NVTSY let me just mention it here. Not exactly small cap. One of 10 largest drug companies in the world and it trades on the BB here. Sad. Anyway, in the next 6-12 months I am moving more $ to pharma so get used to funny symbols. RWR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next